Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Antirelapse Compounds
Open Access
- 8 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (9), 6667-6675
- https://doi.org/10.1021/acs.analchem.0c00547
Abstract
Efforts to eradicate Plasmodium vivax malaria are hampered by the presence of hypnozoites, persisting stages in the liver that can reactivate after prolonged periods of time enabling further transmission and causing renewed disease. Large-scale drug screening is needed to identify compounds with anti-hypnozoite activity, but current platforms rely on time-consuming high-content fluorescence imaging as read-out, limiting assay throughput. We here report an ultrafast and sensitive dual-luciferase-based method to differentiate hypnozoites from liver stage schizonts using a new transgenic P. cynomolgi parasite line that contains Nanoluc driven by the constitutive hsp70 promoter, as well as firefly luciferase driven by the schizont-specific lisp2 promoter. The transgenic parasite line showed similar fitness and drug sensitivity profiles of selected compounds to wild type. We demonstrate robust bioluminescence-based detection of hypnozoites in 96-well and 384-well plate formats, setting the stage for implementation in large scale drug screens.Funding Information
- Bill and Melinda Gates Foundation (OPP1141292)
This publication has 33 references indexed in Scilit:
- Biochemical Similarities and Differences between the Catalytic [4Fe-4S] Cluster Containing Fumarases FumA and FumB from Escherichia coliPLOS ONE, 2013
- Transgenic Fluorescent Plasmodium cynomolgi Liver Stages Enable Live Imaging and Purification of Malaria Hypnozoite-FormsPLOS ONE, 2013
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Use of a Rhesus Plasmodium cynomolgi Model to Screen for Anti-Hypnozoite Activity of Pharmaceutical SubstancesThe American Journal of Tropical Medicine and Hygiene, 2012
- Liver-stage malaria parasites vulnerable to diverse chemical scaffoldsProceedings of the National Academy of Sciences of the United States of America, 2012
- A 95 kDa protein of Plasmodium vivax and P. cynomolgi visualized by three‐dimensional tomography in the caveola–vesicle complexes (Schüffner's dots) of infected erythrocytes is a member of the PHIST familyMolecular Microbiology, 2012
- Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug DiscoveryPLOS ONE, 2011
- Plasmodium vivax: who cares?Malaria Journal, 2008
- Selection of Anopheles stephensi for refractoriness and susceptibility to Plasmodium falciparumMedical and Veterinary Entomology, 1989
- Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note.BMJ, 1980